Aquestive Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	121.17	71.55	23.87	27.27	28.02
Cash & Short-Term Investments	121.17	71.55	23.87	27.27	28.02
Cash Growth	69.36%	199.71%	-12.47%	-2.68%	-11.89%
Accounts Receivable	17.76	7.34	8.47	4.7	12.12
Inventory	6.17	6.04	6.77	5.78	4.04
Other Current Assets	4.17	3.29	1.85	2.13	3.08
Total Current Assets	149.27	88.22	40.97	39.89	47.26
Net Property, Plant & Equipment	8.51	8.98	9.74	9.3	7.78
Other Intangible Assets	-	-	1.28	1.44	0.05
Other Long-Term Assets	2.64	4.22	5.44	6.45	6.9
Total Assets	160.43	101.42	57.42	57.07	61.99
Accounts Payable	29.86	10.29	8.93	9.95	8.31
Accrued Expenses	5.03	5.91	6.5	7.97	8.74
Current Portion of Long-Term Debt	9.99	0.03	0.02	18.7	2.03
Current Portion of Leases	0.63	0.51	0.39	0.26	0.9
Unearned Revenue	1.09	1.05	1.55	1.51	0.77
Other Current Liabilities	1	1.09	0.92	1.15	1.23
Total Current Liabilities	47.61	18.87	18.31	39.53	21.96
Long-Term Debt	27.52	32.5	27.51	33.45	51.55
Long-Term Leases	4.34	4.97	5.4	5.09	1.95
Other Long-Term Liabilities	114.62	105.25	112.69	97.56	68.67
Total Long-Term Liabilities	146.48	142.72	145.6	136.1	122.16
Total Liabilities	194.09	161.58	163.91	175.62	144.13
Common Stock	0.12	0.09	0.07	0.06	0.04
Additional Paid-in Capital	413.21	302.97	212.52	192.6	174.62
Retained Earnings	-447	-363.21	-319.08	-311.21	-256.8
Shareholders' Equity	-33.66	-60.16	-106.49	-118.55	-82.13
Total Liabilities & Equity	160.43	101.42	57.42	57.07	61.99
Total Debt	42.48	38	33.32	57.49	56.42
Net Cash (Debt)	78.69	33.54	-9.45	-30.22	-28.4
Net Cash Growth	134.59%	-	-	-	-
Net Cash Per Share	0.74	0.39	-0.15	-0.62	-0.75
Book Value	-33.66	-60.16	-106.49	-118.55	-82.13
Book Value Per Share	-0.31	-0.69	-1.74	-2.43	-2.16
Tangible Book Value	-33.66	-60.16	-107.77	-119.99	-82.19
Tangible Book Value Per Share	-0.31	-0.69	-1.76	-2.46	-2.16

Updated Mar 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q